Trial intelligence / Profile preview

Propofol versus propofol + ketamine for emergence quality after cholecystectomy

IRCT20260428069192N4Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jul 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Propofol alone with Propofol + ketamine (2 arms). Primary endpoints: Extubation quality, Heart rate and 3 more. Started Jul 2026; status: completed.

02

Drugs

propofolketamine

Beyond the preview

Go deeper on IRCT20260428069192N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260428069192N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call